Titre : Lymphe

Lymphe : Questions médicales fréquentes

Termes MeSH sélectionnés :

Internal-External Control
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lymphe : Questions médicales les plus fréquentes", "headline": "Lymphe : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lymphe : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-23", "dateModified": "2025-02-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lymphe" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Système lymphatique", "url": "https://questionsmedicales.fr/mesh/D008208", "about": { "@type": "MedicalCondition", "name": "Système lymphatique", "code": { "@type": "MedicalCode", "code": "D008208", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.520" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chyle", "alternateName": "Chyle", "url": "https://questionsmedicales.fr/mesh/D002913", "about": { "@type": "MedicalCondition", "name": "Chyle", "code": { "@type": "MedicalCode", "code": "D002913", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.520.150.350" } } } ], "about": { "@type": "MedicalCondition", "name": "Lymphe", "alternateName": "Lymph", "code": { "@type": "MedicalCode", "code": "D008196", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Katsuhisa Ohgi", "url": "https://questionsmedicales.fr/author/Katsuhisa%20Ohgi", "affiliation": { "@type": "Organization", "name": "Division of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan." } }, { "@type": "Person", "name": "Ryo Ashida", "url": "https://questionsmedicales.fr/author/Ryo%20Ashida", "affiliation": { "@type": "Organization", "name": "Division of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan." } }, { "@type": "Person", "name": "Mihoko Yamada", "url": "https://questionsmedicales.fr/author/Mihoko%20Yamada", "affiliation": { "@type": "Organization", "name": "Division of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan." } }, { "@type": "Person", "name": "Katsuhiko Uesaka", "url": "https://questionsmedicales.fr/author/Katsuhiko%20Uesaka", "affiliation": { "@type": "Organization", "name": "Division of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan." } }, { "@type": "Person", "name": "Teiichi Sugiura", "url": "https://questionsmedicales.fr/author/Teiichi%20Sugiura", "affiliation": { "@type": "Organization", "name": "Division of Hepato-Biliary-Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A novel nurse-inteRN mentorship program to improve nurse-physician communication and teamwork in the emergency department.", "datePublished": "2024-10-23", "url": "https://questionsmedicales.fr/article/39443894", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12245-024-00740-z" } }, { "@type": "ScholarlyArticle", "name": "Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry.", "datePublished": "2024-10-13", "url": "https://questionsmedicales.fr/article/39397275", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/eci.14317" } }, { "@type": "ScholarlyArticle", "name": "Pediatric Cranial Stereotactic Radiosurgery: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines.", "datePublished": "2024-10-11", "url": "https://questionsmedicales.fr/article/39390948", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/neuonc/noae204" } }, { "@type": "ScholarlyArticle", "name": "Longitudinal study of association between quality of life and grit in internal medicine residents in Ramathibodi Hospital.", "datePublished": "2024-09-30", "url": "https://questionsmedicales.fr/article/39350135", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-024-06011-y" } }, { "@type": "ScholarlyArticle", "name": "Use of puberty-blocking hormones for gender dysphoria in New Zealand: descriptive analysis and international comparisons.", "datePublished": "2024-09-27", "url": "https://questionsmedicales.fr/article/39326021", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.26635/6965.6587" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Systèmes sanguin et immunitaire", "item": "https://questionsmedicales.fr/mesh/D006424" }, { "@type": "ListItem", "position": 3, "name": "Système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007107" }, { "@type": "ListItem", "position": 4, "name": "Système lymphatique", "item": "https://questionsmedicales.fr/mesh/D008208" }, { "@type": "ListItem", "position": 5, "name": "Lymphe", "item": "https://questionsmedicales.fr/mesh/D008196" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lymphe - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lymphe", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lymphe", "description": "Comment diagnostiquer une obstruction lymphatique ?\nQuels tests pour évaluer la fonction lymphatique ?\nQuels signes indiquent une infection lymphatique ?\nComment détecter un lymphome ?\nQuels examens pour une lymphe anormale ?", "url": "https://questionsmedicales.fr/mesh/D008196?mesh_terms=Internal-External+Control&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lymphe", "description": "Quels sont les symptômes d'un œdème lymphatique ?\nComment reconnaître une infection des ganglions ?\nQuels signes d'une maladie lymphatique ?\nQuels symptômes d'une lymphangite ?\nComment se manifeste un lymphœdème ?", "url": "https://questionsmedicales.fr/mesh/D008196?mesh_terms=Internal-External+Control&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lymphe", "description": "Comment prévenir le lymphœdème ?\nQuelles mesures pour éviter les infections lymphatiques ?\nComment réduire le risque de lymphome ?\nQuelles habitudes pour une bonne santé lymphatique ?\nComment éviter les complications lymphatiques ?", "url": "https://questionsmedicales.fr/mesh/D008196?mesh_terms=Internal-External+Control&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lymphe", "description": "Quels traitements pour le lymphœdème ?\nComment traiter une infection lymphatique ?\nQuelles options pour un lymphome ?\nComment gérer l'œdème lymphatique ?\nQuels médicaments pour les troubles lymphatiques ?", "url": "https://questionsmedicales.fr/mesh/D008196?mesh_terms=Internal-External+Control&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lymphe", "description": "Quelles complications du lymphœdème ?\nQuels risques liés à une obstruction lymphatique ?\nComment le lymphome peut-il évoluer ?\nQuelles conséquences d'une infection lymphatique ?\nQuels effets du traitement du lymphome ?", "url": "https://questionsmedicales.fr/mesh/D008196?mesh_terms=Internal-External+Control&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lymphe", "description": "Quels facteurs augmentent le risque de lymphome ?\nComment le cancer influence-t-il la santé lymphatique ?\nQuels comportements à risque pour le système lymphatique ?\nQuelles infections augmentent le risque lymphatique ?\nComment l'exposition à des toxines affecte-t-elle la lymphe ?", "url": "https://questionsmedicales.fr/mesh/D008196?mesh_terms=Internal-External+Control&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une obstruction lymphatique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen physique, échographie ou IRM peut aider à diagnostiquer une obstruction lymphatique." } }, { "@type": "Question", "name": "Quels tests pour évaluer la fonction lymphatique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme la lymphoscintigraphie permettent d'évaluer la fonction lymphatique." } }, { "@type": "Question", "name": "Quels signes indiquent une infection lymphatique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur, gonflement et douleur au niveau des ganglions lymphatiques peuvent indiquer une infection." } }, { "@type": "Question", "name": "Comment détecter un lymphome ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un lymphome peut être détecté par biopsie, examens sanguins et imageries médicales." } }, { "@type": "Question", "name": "Quels examens pour une lymphe anormale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses sanguines et des biopsies peuvent être nécessaires pour évaluer une lymphe anormale." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un œdème lymphatique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Un œdème lymphatique se manifeste par un gonflement, souvent dans les bras ou les jambes." } }, { "@type": "Question", "name": "Comment reconnaître une infection des ganglions ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les ganglions enflés, sensibles et douloureux sont des signes d'infection." } }, { "@type": "Question", "name": "Quels signes d'une maladie lymphatique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, perte de poids inexpliquée et fièvre peuvent indiquer une maladie lymphatique." } }, { "@type": "Question", "name": "Quels symptômes d'une lymphangite ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, douleur et lignes rouges sur la peau sont des symptômes de lymphangite." } }, { "@type": "Question", "name": "Comment se manifeste un lymphœdème ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Le lymphœdème se manifeste par un gonflement persistant, souvent dans les membres." } }, { "@type": "Question", "name": "Comment prévenir le lymphœdème ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les blessures, maintenir un poids santé et faire de l'exercice régulier aide à prévenir le lymphœdème." } }, { "@type": "Question", "name": "Quelles mesures pour éviter les infections lymphatiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et traiter rapidement les blessures aide à prévenir les infections lymphatiques." } }, { "@type": "Question", "name": "Comment réduire le risque de lymphome ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition à des produits chimiques nocifs et maintenir un mode de vie sain peut réduire le risque de lymphome." } }, { "@type": "Question", "name": "Quelles habitudes pour une bonne santé lymphatique ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, l'hydratation et l'exercice régulier favorisent la santé lymphatique." } }, { "@type": "Question", "name": "Comment éviter les complications lymphatiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Surveiller les symptômes et consulter un médecin rapidement aide à éviter les complications lymphatiques." } }, { "@type": "Question", "name": "Quels traitements pour le lymphœdème ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut le drainage lymphatique, les bandages compressifs et la kinésithérapie." } }, { "@type": "Question", "name": "Comment traiter une infection lymphatique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les infections lymphatiques sont généralement traitées avec des antibiotiques." } }, { "@type": "Question", "name": "Quelles options pour un lymphome ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement du lymphome peut inclure chimiothérapie, radiothérapie ou greffe de moelle osseuse." } }, { "@type": "Question", "name": "Comment gérer l'œdème lymphatique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La gestion de l'œdème lymphatique passe par des exercices, des soins de la peau et des vêtements compressifs." } }, { "@type": "Question", "name": "Quels médicaments pour les troubles lymphatiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anti-inflammatoires et des diurétiques peuvent être prescrits pour les troubles lymphatiques." } }, { "@type": "Question", "name": "Quelles complications du lymphœdème ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Le lymphœdème peut entraîner des infections, des douleurs chroniques et des limitations fonctionnelles." } }, { "@type": "Question", "name": "Quels risques liés à une obstruction lymphatique ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une obstruction lymphatique peut causer des infections, des douleurs et des troubles circulatoires." } }, { "@type": "Question", "name": "Comment le lymphome peut-il évoluer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le lymphome peut évoluer vers des stades avancés, nécessitant des traitements plus agressifs." } }, { "@type": "Question", "name": "Quelles conséquences d'une infection lymphatique ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les infections lymphatiques non traitées peuvent entraîner des complications graves, comme la septicémie." } }, { "@type": "Question", "name": "Quels effets du traitement du lymphome ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements du lymphome peuvent causer des effets secondaires comme la fatigue, nausées et immunosuppression." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de lymphome ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, des antécédents familiaux et certaines infections virales augmentent le risque de lymphome." } }, { "@type": "Question", "name": "Comment le cancer influence-t-il la santé lymphatique ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le cancer et ses traitements peuvent endommager le système lymphatique, augmentant le risque d'œdème." } }, { "@type": "Question", "name": "Quels comportements à risque pour le système lymphatique ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'obésité et une mauvaise alimentation sont des comportements à risque pour le système lymphatique." } }, { "@type": "Question", "name": "Quelles infections augmentent le risque lymphatique ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des infections comme le VIH et certaines infections bactériennes peuvent augmenter le risque lymphatique." } }, { "@type": "Question", "name": "Comment l'exposition à des toxines affecte-t-elle la lymphe ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition à des toxines environnementales peut altérer la fonction lymphatique et augmenter les risques de maladies." } } ] } ] }

Sources (10000 au total)

A novel nurse-inteRN mentorship program to improve nurse-physician communication and teamwork in the emergency department.

Communication between nurses and physicians is essential to providing patient care in the emergency department. The American College of Graduate Medical Education includes interpersonal and communicat... We used Kern's Six-step approach to develop and implement this program. We then evaluated the program's impact with a pre-program and post-program 12-question survey to evaluate participation, perceiv... 13 interns and 22 nurses participated in the program. All 13 interns and 19 of 22 nurses completed the pre-program survey. 10 of 13 interns and 11 of 22 nurse mentors completed the post-program survey... We were able to successfully implement a one-year nurse-intern mentorship program aiming to promote communication, collaboration and professional development. Our results show differing attitudes betw...

Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry.

The clinical relevance of cardiac troponin (cTn) elevation in takotsubo syndrome (TTS) remains uncertain. The present study sought to investigate the role of cardiac troponin (cTn) elevations in morta... Patients enrolled in the International Takotsubo (InterTAK) Registry from January 2011 to February 2020 with available data on peak cTn levels were included in the analysis. Peak cTn levels during the... Out of 2'938 patients, 222 (7.6%) patients died during 1-year follow-up. A more than 28.8-fold increase of cTn above the upper reference limit was identified as threshold for clinically relevant myoca... This study for the first time determined a troponin threshold for the identification of TTS patients at excess risk of mortality. These findings advance risk stratification in TTS and assist in identi...

Pediatric Cranial Stereotactic Radiosurgery: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines.

There are limited data on the use of stereotactic radiosurgery (SRS) for pediatric patients. The aim of this systematic review was to summarize indications and outcomes specific to pediatric cranial S... A systematic review, using the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), analyzed English-language articles on SRS, published between 1989 and 2021... Of the 113 articles identified for review, 68 met the inclusion criteria. These articles described approximately 400 pediatric patients with benign and malignant brain tumors and 5119 with AVMs who un... This review is the first to summarize outcomes specific to SRS for pediatric brain tumors and AVMs. Although data reporting is limited for pediatric patients, SRS appears to provide acceptable rates o...

Longitudinal study of association between quality of life and grit in internal medicine residents in Ramathibodi Hospital.

Grit refers to a combination of perseverance and passion, which is essential for long-term success. Grit is associated with higher education attainment and a lower likelihood of burnout. Understanding... We conducted a prospective study involving internal medicine residents enrolled in training programs from July 2022 to July 2023, except for the second-third-year residents of dermatology and neurolog... Of 122 internal medicine residents in all three years of training, one resident dropped out during training, and another declined to participate. A total of 120 residents were included. Grit did not s... Of all residents, grit did not change over a year. However, only the first-year residents reported a decrease in grit during a training year. Throughout first-year residents' internal medicine residen...

Use of puberty-blocking hormones for gender dysphoria in New Zealand: descriptive analysis and international comparisons.

To investigate use of puberty-blocking hormones (gonadotropin-releasing hormone analogues [GnRHa]) for gender dysphoria in New Zealand. Specifically, to describe demographic characteristics and time t... The national Pharmaceutical Collection was used to identify all dispensing from 2006 to 2023 to those aged <18, by sex/gender and age. Cumulative incidence of first prescriptions between ages 12 and 1... In New Zealand, prescription of GnRHa for gender dysphoria started around 2011; prevalence of use increased to 2014, then more steeply to 2022, followed by a decline. Incidence data show the decline s... The high rate of prescribing for probable gender dysphoria in New Zealand, and the decline after 2021, require further investigation....

Dermatologic Conditions in Down Syndrome: A Multi-Site Retrospective Review of International Classification of Diseases Codes.

As the population and life expectancy of people with Down syndrome increases, identifying common skin conditions throughout the lifespan will help inform clinical care and research. We sought to evalu... This multicenter retrospective study analyzed demographic and outpatient visit International Classification of Diseases codes of patients with Down syndrome evaluated at outpatient dermatology clinics... A total of 1529 patients with Down syndrome were identified from eight academic medical centers: 50.8% were children (0-12 years), 25.2% were adolescents (13-17 years), and 24% were adults (18 years a... Dermatologic conditions in patients with Down syndrome vary by age, but are most often eczematous, adnexal, and cutaneous autoimmune disorders. This multicenter retrospective review identifies skin di...

Assessment of liver graft quality during hypothermic oxygenated perfusion: the first international validation study.

While it is currently assumed that liver assessment is only possible during normothermic machine perfusion (NMP), there is uncertainty regarding a reliable and quick prediction of graft injury during ... Perfusate samples of human livers from 10 centers in 7 countries with HOPE-experience were analyzed for released mitochondrial compounds, i.e. flavin mononucleotide (FMN), NADH, purine derivates and i... We collected 473 perfusate samples of human DCD (n=315) and DBD livers (n=158). Fluorometric assessment of FMN in perfusate was validated by mass spectrometry (R=0.7011,p<0.0001). Graft loss due to pr... This first international study validates the predictive value of the mitochondrial co-factor FMN, released from complex I during HOPE, and may therefore contribute to a better risk stratification of i... Analysis of 473 perfusates, collected from 10 international centers during hypothermic oxygenated perfusion (HOPE), revealed that mitochondria derived flavin mononucleotide (FMN) values in perfusate i...